Cavaliere Franco, Masieri Simonetta
Institute of Anaesthesia and Intensive Care, Catholic University of the Sacred Heart, Largo Francesco Vito, 1, 00168 Rome, Italy.
Expert Opin Drug Saf. 2005 Nov;4(6):1125-33. doi: 10.1517/14740338.4.6.1125.
In the past, corticosteroids were given to head-injured patients in order to prevent secondary brain damage, even if clinical trials had been inconclusive and potential risks of complications were of concern. Recently, CRASH, a large, multi-centre study on short-term, high-dose corticosteroid treatment in head trauma, was interrupted after enrolling > 10,000 patients because corticosteroid treatment was associated with significantly higher mortality within two weeks. Participating clinicians were not requested to judge the causes of death, but rates of infections and gastrointestinal haemorrhages did not differ between treated patients and controls. Other potential corticosteroid complications include metabolic derangements (particularly hyperglycaemia), adrenal insufficiency and critical illness myopathy. Furthermore, experimental data suggest that corticosteroids may have some harmful effects on neural tissue. In this review, the potential risks of treating head-injured patients with corticosteroids are examined.
过去,即便临床试验结果尚无定论且并发症的潜在风险令人担忧,皮质类固醇仍被用于头部受伤患者以预防继发性脑损伤。最近,一项关于头部创伤短期大剂量皮质类固醇治疗的大型多中心研究CRASH,在招募了超过10000名患者后中断,因为皮质类固醇治疗与两周内显著更高的死亡率相关。未要求参与的临床医生判断死亡原因,但治疗患者与对照组之间的感染率和胃肠道出血率并无差异。皮质类固醇的其他潜在并发症包括代谢紊乱(尤其是高血糖)、肾上腺功能不全和危重病性肌病。此外,实验数据表明皮质类固醇可能对神经组织有一些有害影响。在本综述中,研究了用皮质类固醇治疗头部受伤患者的潜在风险。